2/11
09:00 am
dcoy
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
Low
Report
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
2/5
09:54 am
dcoy
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial [Yahoo! Finance]
Medium
Report
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial [Yahoo! Finance]
2/5
09:15 am
dcoy
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Low
Report
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
2/4
09:02 am
dcoy
Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement
Medium
Report
Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement
1/23
05:06 pm
dcoy
Decoy Therapeutics (NASDAQ:DCOY) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
Low
Report
Decoy Therapeutics (NASDAQ:DCOY) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
1/23
08:04 am
dcoy
Decoy Therapeutics (NASDAQ:DCOY) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $2.50 price target on the stock.
Low
Report
Decoy Therapeutics (NASDAQ:DCOY) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $2.50 price target on the stock.
1/13
08:15 am
dcoy
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
High
Report
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform